In Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024 No Comments

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

Author admin

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.
Your name

Your email
By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.